Bullish indicating open at $55-$60, IPO prices at $37
Investing.com -- 180 Life Sciences Corp. (NASDAQ:ATNF), now doing business as ETHZilla, saw its stock surge 75% after announcing it holds 82,186 Ethereum tokens currently valued at approximately $349 million.
The company revealed it has accumulated the substantial ETH position at an average acquisition price of $3,806.71 per token. In addition to its cryptocurrency holdings, ETHZilla also maintains approximately $238 million in USD cash equivalents, bringing its total treasury to nearly $587 million.
"At ETHZilla we have put over $350 million in capital to work since the PIPE transaction we completed last week, and have executed on our strategy to rapidly build a differentiated Ethereum treasury vehicle," said McAndrew Rudisill, Executive Chairman of the company.
The firm stated that its most recently purchased ETH is expected to be held long-term and staked through Electric Capital’s proprietary Ethereum network strategies to generate yield. Rudisill noted that the ETH reserve "will unlock cash flow for our shareholders as we seek to deliver on our on-chain yield generation program."
According to the company’s disclosure, ETHZilla has 154.032 million shares outstanding as of August 5, 2025. The company indicated it will continue to provide updates on its treasury and on-chain yield generation strategies through public releases and regulatory filings.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.